Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease

Affiliations

• ¹ University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
• ² Department of Hepatology and Transplant, Hospital Médica Sur, Mexico City, Mexico; Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Asociación Latinoamericana para el Estudio del Hígado (ALEH), Santiago, Chile.
• ³ Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; European Association for the Study of the Liver (EASL), Geneva, Switzerland. Electronic address: Aleksander.Krag@rsyd.dk.
• ⁴ Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; American Association for the Study of Liver Diseases (AASLD), Alexandria, USA.
• ⁵ National Institute for Health Research, Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.